Biomarin
BioMarin develops and commercialises innovative biopharmaceuticals for rare diseases driven by genetic causes.
Financial Data
-
31st Dec 17 Source: CRO
- €491.6 million turnover
-
€1 million
profit - 300 employees
-
31st Dec 16 Source: CRO
- €377.3 million turnover
-
€0.1 million
profit - 236 employees
- 2 more years available »
Ranking
By Turnover
(€491.6 million)- 155th in Top Companies
- 22nd in Health
By Employees
(300)- 474th in Top Companies
- 69th in Health
- 300
- €491.6 million
Employees
- Michael O’Donnell CEO/Managing Director
Latest News
- 9:52am Brexit drives two more American financial service groups to Dublin
- 9:27am Q&A: What does the collapse of Thomas Cook mean?
- 8:14am Revenues soar by 66% at virtual reality company VR Education
- 7:39am Record numbers of UK lawyers register in Ireland
- 7:23am Thomas Cook collapses after knife-edge rescue talks fail